Table 2.
TE detection | Studies, N | Etiology | TE cut-off | Se | Sp | PPV | NPV | AUROC |
---|---|---|---|---|---|---|---|---|
Portal hypertension | 2 | Total | ≥8.0-8.74 | 0.88 (0.86-0.90) | 0.74 (0.67-0.81) | 0.83 (0.81-0.84) | 0.88 (0.85-0.90) | 0.86 (0.79-0.92) |
1 | Alcoholic | ≥10 | 0.85 | 0.79 | 0.86 | 0.75 | 0.74 (0.70-0.76) | |
Significant portal hypertension | 8 | Total | ≥13.6-21.0 | 0.87 (0.63-0.97) | 0.71 (0.50-0.93) | 0.84 (0.56-0.97) | 0.76 (0.35-0.92) | 0.88 (0.76-0.99) |
3 | Alcoholic | ≥19.0-34.9 | 0.90 (0.89-0.90) | 0.81 (0.73-0.88) | 0.94 (0.89-0.98) | 0.74 (0.64-0.84) | 0.88 (0.80-0.94) | |
Severe portal hypertension | 5 | Total | ≥17.6-23.0 | 0.76 (0.53-0.94) | 0.82 (0.67-0.92) | 0.85 (0.79-0.95) | 0.76 (0.58-0.91) | 0.85 (0.79-0.92) |
1 | Alcoholic | ≥23.0 | 0.91 | 0.77 | 0.87 | 0.80 | 0.79 (0.73-0.86) |
TE, transient elastography; PH, portal hypertension; PPV, positive predictive value; NPV, negative predictive value; AUROC, area under the receiver operating characteristic curve.